T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$1.36B |
| 2 |
Philip Morris
PM
|
+$1.3B |
| 3 |
Amazon
AMZN
|
+$1.21B |
| 4 |
Stryker
SYK
|
+$1.12B |
| 5 |
AET
Aetna Inc
AET
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$1.46B |
| 2 |
Gilead Sciences
GILD
|
+$1.1B |
| 3 |
Walt Disney
DIS
|
+$866M |
| 4 |
Akamai
AKAM
|
+$703M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.69% |
| 2 | Consumer Discretionary | 15.01% |
| 3 | Financials | 13.64% |
| 4 | Technology | 12.55% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTWS
2001
DELISTED
Connecticut Water Service Inc
CTWS
| $459K | ﹤0.01% |
10,180
-1,100
| -10% | -$45.8K |
|
2002
Kratos Defense & Security Solutions
KTOS
$11.8B
| $458K | ﹤0.01% |
92,557
| – | – |
|
2003
Tompkins Financial
TMP
$1.45B
| $458K | ﹤0.01% |
7,151
| – | – |
|
|
RDUS
2004
DELISTED
Radius Health, Inc.
RDUS
| $458K | ﹤0.01% |
14,560
+7,512
| +107% | +$260K |
|
|
KG
2005
Kestrel Group
KG
$62.3M
| $456K | ﹤0.01% |
1,762
+357
| +25% | +$92.7K |
|
|
GTY
2006
Getty Realty Corp
GTY
$2.06B
| $454K | ﹤0.01% |
22,885
+125
| +0.5% | +$2.25K |
|
2007
Hecla Mining
HL
$11.9B
| $454K | ﹤0.01% |
163,300
-100,000
| -38% | -$226K |
|
|
KND
2008
DELISTED
Kindred Healthcare
KND
| $454K | ﹤0.01% |
36,776
+17,800
| +94% | +$185K |
|
|
FFIC
2009
DELISTED
Flushing Financial
FFIC
| $453K | ﹤0.01% |
20,975
| – | – |
|
2010
Delek US
DK
$4.18B
| $450K | ﹤0.01% |
29,550
+3,200
| +12% | +$51.6K |
|
2011
OneMain Financial
OMF
$7.52B
| $450K | ﹤0.01% |
16,407
| – | – |
|
2012
3D Systems Corp
DDD
$598M
| $449K | ﹤0.01% |
29,006
| – | – |
|
2013
Benchmark Electronics
BHE
$2.89B
| $448K | ﹤0.01% |
19,415
+4,900
| +34% | +$103K |
|
2014
Merit Medical Systems
MMSI
$5.4B
| $448K | ﹤0.01% |
24,216
+5,410
| +29% | +$93.8K |
|
|
SMLR
2015
DELISTED
Semler Scientific
SMLR
| $442K | ﹤0.01% |
214,477
| – | – |
|
|
EBIX
2016
DELISTED
Ebix Inc
EBIX
| $439K | ﹤0.01% |
10,772
-2,600
| -19% | -$90.8K |
|
2017
Rigel Pharmaceuticals
RIGL
$763M
| $438K | ﹤0.01% |
21,036
-129
| -0.6% | -$3.18K |
|
|
DOOR
2018
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $438K | ﹤0.01% |
+6,680
| New | +$377K |
|
2019
CNX Resources
CNX
$5.24B
| $436K | ﹤0.01% |
46,308
-2,015,708
| -98% | -$14.7M |
|
2020
Rogers Corp
ROG
$2.47B
| $431K | ﹤0.01% |
7,200
+2,300
| +47% | +$116K |
|
2021
OneSpan
OSPN
$624M
| $430K | ﹤0.01% |
27,900
+6,800
| +32% | +$101K |
|
|
SNCR
2022
DELISTED
Synchronoss Technologies
SNCR
| $430K | ﹤0.01% |
1,478
+256
| +21% | +$66.7K |
|
2023
Caleres
CAL
$461M
| $428K | ﹤0.01% |
15,140
+3,500
| +30% | +$93K |
|
2024
German American Bancorp
GABC
$1.92B
| $428K | ﹤0.01% |
19,940
| – | – |
|
|
RSTI
2025
DELISTED
Rofin-Sinar Technologies Inc
RSTI
| $428K | ﹤0.01% |
13,270
| – | – |
|
Similar funds
T. Rowe Price Associates's Q1 2016 Portfolio in Review
As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
- T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
- T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
- T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
- T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
- T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.
Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.